Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell E Ware

Showing results (81-90 of 267) with videos related to

Pageof 27
Sort By:
Pediatric Blood & Cancer|May 7, 2009
Simultaneous acute splenic sequestration and transient aplastic crisis in children with sickle cell diseaseAmber Mayfield Yates, Jane S Hankins, Nicole A Mortier, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|October 30, 2016
Pilot of the Chronic Disease Self-Management Program for Adolescents and Young Adults With Sickle Cell DiseaseLori E Crosby, Naomi E Joffe, James Peugh, et al.
Clinical Chemistry|October 4, 2016
Stable-Isotope Dilution HPLC-Electrospray Ionization Tandem Mass Spectrometry Method for Quantifying Hydroxyurea in Dried Blood SamplesAnu Marahatta, Vandana Megaraj, Patrick T McGann, et al.
American Journal of Hematology|November 6, 2015
Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell diseasePatrick T McGann, Beverly A Schaefer, Mary Paniagua, et al.
Biomedicines|December 30, 2020
Electrochemical Determination of Hydroxyurea in a Complex Biological Matrix Using MoS<sub>2</sub>-Modified Electrodes and ChemometricsRemi Cazelles, Rajendra P Shukla, Russell E Ware, et al.
Blood|April 13, 2007
Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemiaSherri A Zimmerman, William H Schultz, Shelly Burgett, et al.
British Journal of Haematology|May 6, 2011
Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposurePatrick T McGann, Thad A Howard, Jonathan M Flanagan, et al.
Haematologica|April 10, 2010
Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse modelJeffrey D Lebensburger, Tamara I Pestina, Russell E Ware, et al.
The Journal of Pediatrics|March 16, 2020
Hydroxyurea Exposure in Lactation: a Pharmacokinetics Study (HELPS)Russell E Ware, Anu Marahatta, Julie L Ware, et al.
American Journal of Hematology|November 12, 2024
Globalization in clinical drug development for sickle cell diseaseEnrico Costa, Russell E Ware, Léon Tshilolo, et al.
Pageof 27

Showing results (81-90 of 267) with videos related to

Sort By:
Pageof 27
Pediatric Blood & Cancer|May 7, 2009
Simultaneous acute splenic sequestration and transient aplastic crisis in children with sickle cell diseaseAmber Mayfield Yates, Jane S Hankins, Nicole A Mortier, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|October 30, 2016
Pilot of the Chronic Disease Self-Management Program for Adolescents and Young Adults With Sickle Cell DiseaseLori E Crosby, Naomi E Joffe, James Peugh, et al.
Clinical Chemistry|October 4, 2016
Stable-Isotope Dilution HPLC-Electrospray Ionization Tandem Mass Spectrometry Method for Quantifying Hydroxyurea in Dried Blood SamplesAnu Marahatta, Vandana Megaraj, Patrick T McGann, et al.
American Journal of Hematology|November 6, 2015
Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell diseasePatrick T McGann, Beverly A Schaefer, Mary Paniagua, et al.
Biomedicines|December 30, 2020
Electrochemical Determination of Hydroxyurea in a Complex Biological Matrix Using MoS<sub>2</sub>-Modified Electrodes and ChemometricsRemi Cazelles, Rajendra P Shukla, Russell E Ware, et al.
Blood|April 13, 2007
Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemiaSherri A Zimmerman, William H Schultz, Shelly Burgett, et al.
British Journal of Haematology|May 6, 2011
Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposurePatrick T McGann, Thad A Howard, Jonathan M Flanagan, et al.
Haematologica|April 10, 2010
Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse modelJeffrey D Lebensburger, Tamara I Pestina, Russell E Ware, et al.
The Journal of Pediatrics|March 16, 2020
Hydroxyurea Exposure in Lactation: a Pharmacokinetics Study (HELPS)Russell E Ware, Anu Marahatta, Julie L Ware, et al.
American Journal of Hematology|November 12, 2024
Globalization in clinical drug development for sickle cell diseaseEnrico Costa, Russell E Ware, Léon Tshilolo, et al.
Pageof 27